Gregory P. Fusco, MD, MPH

Chief Executive Officer & Chief Medical Officer
Epividian, Inc.

Disclosure(s): AIDS Healthcare Foundation: Client of employer; EMD: Grant/Research Support; Gilead Sciences: Client of employer; Janssen: Client of employer; Merck & Co.: Client of employer; Theratechnologies: Client of employer; ViiV Healthcare: Client of employer

Poster(s):

• 441 - Association between Incident HIV-Associated Wasting/Low Weight and All-Cause Mortality in the OPERA^® Cohort
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 1264 - Durability and effectiveness of fostemsavir in heavily treatment-experienced people with HIV
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET

• 1284 - Suppressed Switch to DTG/3TC 2-Drug Regimen Vs. BIC- or DTG-Based 3-Drug Regimens
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET